TREM2-expressing macrophages in liver diseases
Trends in Endocrinology & Metabolism · 2026-01 · 37 (1) · 55-67
DOI: 10.1016/j.tem.2025.04.009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Endocrinology & Metabolism, 2026-01. Verfasst von Xiaochen Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510030, China; Department of Immunolo…. Hauptthemen laut MEDLINE: Receptors, Immunologic, Membrane Glycoproteins, Macrophages, Liver Diseases. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 30% of the global population and spans a spectrum of liver abnormalities, including simple steatosis, inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Recent studies have identified triggering receptors expressed on myeloid cells 2 (TREM2)-expressing macrophages as key regulators of MASLD progression. TREM2 plays a pivotal role in regulating macrophage-mediated processes such as efferocytosis, inflammatory control, and fibrosis resolution. Additionally, soluble TREM2 (sTREM2) was proposed as a noninvasive biomarker for diagnosing and monitoring MASLD progression. However, the molecular mechanisms through which TREM2 influences MASLD pathogenesis remain incompletely understood. This review summarizes the current understanding of TREM2-expressing macrophages in MASLD, with the goal of illuminating future research and guiding the development of innovative therapeutic strategies targeting TREM2 signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510030, China; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390,…
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. El…
Förderung
- NIDDK NIH HHS
- NIGMS NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
- Cancer Prevention and Research Institute of Texas
- NIH National Institute of General Medical Sciences
Zitieren
APA
Wang, X., Qiu, Z., Zhong, Z., & Liang, S. (2026). TREM2-expressing macrophages in liver diseases. Trends in Endocrinology & Metabolism, 37(1), 55-67. https://doi.org/10.1016/j.tem.2025.04.009
Vancouver
Wang X, Qiu Z, Zhong Z, Liang S. TREM2-expressing macrophages in liver diseases. Trends in Endocrinology & Metabolism. 2026;37(1):55-67. doi:10.1016/j.tem.2025.04.009
BibTeX
@article{Wang2026,
author = {Wang, Xiaochen and Qiu, Zhiyu and Zhong, Zhenyu and Liang, Shuang},
title = {TREM2-expressing macrophages in liver diseases},
journal = {Trends in Endocrinology & Metabolism},
year = {2026},
volume = {37},
number = {1},
pages = {55--67},
doi = {10.1016/j.tem.2025.04.009}
}
EUVIMED